Criterion 21: #164989

Published Date: 
July 22, 2016

The provider participates in a national system framework for quality improvement in clinical trials research.  This program supports the quality of clinical trials research, including human subjects’ protection requirements on a national basis.  In addition, the provider’s educational programming is based on the Food and Drug Administration’s inspection outcomes regarding clinical research practices and is implemented in collaboration with the Food and Drug Administration. 

Was this useful?